161 Results for "

side-effects

" in MedChemExpress (MCE) Product Catalog:
Products (161)

161 Results for "side-effects" in MCE Product Catalog:

Cat. No.: HY-123352
CAS No.: 669073-68-1
Purity:  98.59%
Synonyms: (+)-ZK 216348
ZK 216348 ((+)-ZK 216348) is a nonsteroidal selective glucocorticoid receptor agonist with an IC50 of 20.3 nM. ZK 216348 also binds to Progesterone and mineralocorticoid receptors with IC50s of 20.4 nM and 79.9 nM, respectively. ZK 216348 has antiinflammatory activity similar to Prednisolone and induces less transactivation-mediated side effects .
loading...
    loading...
Cat. No.: HY-155113
CAS No.: 3031078-90-4
Target:  

PROTACs HSP

Research Areas:  

Cancer

PROTAC Hsp90α degrader 1 is a selective PROTAC Hsp90α degrader with a DC50 of 0.295 μM. PROTAC Hsp90α degrader 1 exhibits antitumor activity with low toxic side effects. PROTAC Hsp90α degrader 1 can be used for the research of breast cancer .
loading...
    loading...
Cat. No.: HY-107345
CAS No.: 90101-16-9
Synonyms: Ombolan
Research Areas:  

Inflammation/Immunology

Droxicam (Ombolan) is a non-steroidal anti-inflammatory agent, with strong analgesic activity. Droxicam acts by inhibiting PGE2 varies, and is characterised by being a pro-drug of Piroxicam (HY-B0253). Droxicam is well tolerated with slight side effects in the said mucosa. Droxicam does not show cardiovascular or respiratory effects in cats, and inhibits peritoneal capillary permeability in mouse .
loading...
    loading...
Cat. No.: HY-103409
CAS No.: 587870-77-7
Purity:  99.05%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

ABT-724 trihydrochloride is a potent and highly selective dopamine D4 receptor agonist with an EC50 of 12.4 nM for human dopamine D4 receptor. ABT-724 trihydrochloride is a potent partial agonist at the rat D4 (EC50 of 14.3 nM) and the ferret D4 receptor (EC50 of 23.2 nM), and has no effect on dopamine D1, D2, D3, or D5 receptors. ABT-724 trihydrochloride could be useful for the treatment of erectile dysfunction and has favorable side-effect profile .
loading...
    loading...
Cat. No.: HY-16103
CAS No.: 30392-41-7
Synonyms: Win 32784; Bitolterol methanesulfonate; S-1540 mesylate
Target:  

Drug Derivative

Research Areas:  

Infection

Bitolterol mesylate (WIN 37284) is a diester-type agonist amine bronchodilator without significant cardiac side effects .
loading...
    loading...
Cat. No.: HY-115709
CAS No.: 30688-66-5
Target:  

Drug Derivative

Research Areas:  

Cancer

4,6-O-Benzylidene-D-glucose is a benzaldehyde derivative. 4,6-O-Benzylidene-D-glucose exerts anticancer effects without causing side effects .
loading...
    loading...
Cat. No.: HY-13556
CAS No.: 182133-25-1
Synonyms: LY353381; SERM III
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease Cancer

Arzoxifene (LY353381) is an orally active selective estrogen receptor modulator with a fixed ring structure similar to raloxifene. Arzoxifene has minimal side effects with powerful antiestrogenic effects on breast cancer and endometrium, with equally strong favorable estrogenic effects on bone and lipid profile .
loading...
    loading...
Cat. No.: HY-P99436
CAS No.: 1370261-50-9
Synonyms: ABR-214936
Anatumomab mafenatox (ABR-214936) is a 73 KDa recombinant protein to recognize the tumor-associated antigen 5T4, which is widely expressing in malignancy. Anatumomab mafenatox is between a modified form of SEA and a murine Fab. The main side effects of Anatumomab mafenatox are reported to include fever, low blood pressure, pain, nausea and drowsiness .
loading...
    loading...
Cat. No.: HY-107932
CAS No.: 67-78-7
Research Areas:  

Inflammation/Immunology

Triamcinolone diacetate is a synthetic derivative of glucocorticoid. Triamcinolone diacetate has anti-inflammatory activity. Triamcinolone diacetate can be used in research on dermatomyositis, Bell's palsy and rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-N1965
CAS No.: 490-67-5
Gaultherin is an orally active non-steroidal anti-inflammatory agent. Gaultherin selectively inhibits NF-κB, MAPK, COX-2 (IC50 = 0.35 mg/mL), LOX (IC50 = 0.56 mg/mL) and HYAL (IC50 = 28.58 μg/mL) to exert anti-inflammatory, antipyretic and analgesic effects. Gaultherin exhibits modest direct antioxidant capacity, greater in cell-based models. Gaultherin does not affect COX-1 so that avoids the common gastrointestinal side effects of Aspirin (HY-14654) .
loading...
    loading...
Cat. No.: HY-136281
CAS No.: 135135-87-4
Purity:  98.82%
Target:  

Sigma Receptor

Research Areas:  

Neurological Disease

DuP 734 is a sigma receptor antagonist. DuP 734 is a selective and potent sigma and 5-HT2 receptor ligand with weak affinity for D2 receptors. DuP 734 may have antipsychotic activity without the liability of motor side effects typical of neuroleptics .
loading...
    loading...
Cat. No.: HY-179511
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

α-Glucosidase-IN-104 (Compound 9s) is an efficient inhibitor of α-glucosidase with an IC50 of 24.32 μM. α-Glucosidase-IN-104 has a weak inhibitory effect on α-amylase and avoids gastrointestinal side effects. α-Glucosidase-IN-104 can be used for research on type 2 diabetes .
loading...
    loading...
Cat. No.: HY-118249
CAS No.: 1168138-37-1
Target:  

PPAR

Research Areas:  

Neurological Disease

GSK 1997132B is a benzimidazole-based PPARγ partial agonist that can cross the blood-brain barrier with a pEC50 value of 8.0. GSK 1997132B has no significant effect on PPARα/δ. GSK 1997132B improves the problem of high blood clearance rate of earlier compounds, avoiding side effects such as weight gain and edema. GSK 1997132B can be used for research on Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-14330
CAS No.: 70006-24-5
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

ABT-724, a chemical probe, is a potent and highly selective dopamine D4 receptor agonist with an EC50 of 12.4 nM for human dopamine D4 receptor. ABT-724 is a potent partial agonist at the rat D4 (EC50 of 14.3 nM) and the ferret D4 receptor (EC50 of 23.2 nM). ABT-724 has no effect on dopamine D1, D2, D3, or D5 receptors. ABT-724 could be useful for the treatment of erectile dysfunction and has favorable side-effect profile .
loading...
    loading...
Cat. No.: HY-U00045
CAS No.: 98123-83-2
Synonyms: BRL-38705
Target:  

Parasite

Research Areas:  

Others

Epsiprantel (BRL-38705) is a compound with anti-Echinococcus activity that can cause the death of protoscolex, larvae and adults in vitro, and is more effective against mature worms than larvae in vivo, with no side effects.
loading...
    loading...
Cat. No.: HY-122281
CAS No.: 194358-72-0
Target:  

Cannabinoid Receptor

Research Areas:  

Others

JTE 7-31 selectively acts on peripheral cannabinoid receptors, minimizing central nervous system side effects. They exhibit potent immunomodulatory, anti-inflammatory and anti-allergic properties, as well as inhibitory effects on nephritis .
loading...
    loading...
Cat. No.: HY-106983
CAS No.: 192057-17-3
Research Areas:  

Inflammation/Immunology

GR 250495X is an inhaled glucocorticoid receptor agonist. GR 250495X is designed as a antedrug, which takes effect locally in the lungs but is rapidly metabolized and inactivated in the bloodstream after entering the systemic circulation, thereby minimizing systemic side effects. GR 250495X can be used in asthma research .
loading...
    loading...
Cat. No.: HY-19233
CAS No.: 155210-57-4
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

BAM-1110 is a dopamine receptor agonist. BAM-1110 exhibits dose-dependent antiparkinsonian activity in MPTP (HY-W114750)-treated monkey models of Parkinson's disease. BAM-1110 has minimal side effects and can be used for the research of Parkinson's disease and other neurological disorders .
loading...
    loading...
Cat. No.: HY-106605
CAS No.: 61325-80-2
Synonyms: LY 120363
Research Areas:  

Neurological Disease

Flumezapine (LY 120363) is a potent and balanced antagonist of the dopamine D2 receptor and the 5-hydroxytryptamine receptor (5-HT receptor). Flumezapine does not alter the increase in serum cortisol caused by κ-opioid receptor agonists. Flumezapine inhibits the conditioned avoidance response in rats and has a low risk of extrapyramidal side effects. Flumezapine can be used in antipsychotic research .
loading...
    loading...
Cat. No.: HY-155313
Research Areas:  

Cancer

β-Glucuronide-NB-bis[N(Me)-methyl ester]-MMAE (compound 20) is auristatins-glucuronide conjugate. Antitumor agent-122 shows in vitro antiproliferative activities against β-glucuronidase pretreated and untreated cancer cells with an IC50 value of 5.7 nM - 9.7 nM. Antitumor agent-122 shows potent antitumor efficacy in HCT-116 xenograft mouse model without inducing side effects .
loading...
    loading...